186 related articles for article (PubMed ID: 37619597)
1. Prognostic Factors and Resectability Predictors in Insular Gliomas: A Systematic Review.
Papadopoulou A; Kumar NS
J Neurol Surg A Cent Eur Neurosurg; 2024 Jan; 85(1):74-87. PubMed ID: 37619597
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Transcortical insular glioma resection: clinical outcome and predictors.
Hameed NUF; Qiu T; Zhuang D; Lu J; Yu Z; Wu S; Wu B; Zhu F; Song Y; Chen H; Wu J
J Neurosurg; 2018 Oct; 131(3):706-716. PubMed ID: 30485243
[TBL] [Abstract][Full Text] [Related]
4. Putamen involvement and survival outcomes in patients with insular low-grade gliomas.
Wang Y; Wang Y; Fan X; Li S; Liu X; Wang J; Jiang T
J Neurosurg; 2017 Jun; 126(6):1788-1794. PubMed ID: 27564467
[TBL] [Abstract][Full Text] [Related]
5. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas.
Eseonu CI; ReFaey K; Garcia O; Raghuraman G; Quinones-Hinojosa A
World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.
Eatz TA; Eichberg DG; Lu VM; Di L; Komotar RJ; Ivan ME
J Neurooncol; 2022 Jan; 156(2):233-256. PubMed ID: 34989964
[TBL] [Abstract][Full Text] [Related]
7. Genomic Prognosticators and Extent of Resection in Molecularly Subtyped World Health Organization Grade II and III Gliomas-A Single-Institution, Nine-Year Data.
Lasica AB; Jaunmuktane Z; Fersht N; Kirkman MA; Dixon L; Hoskote C; Brandner S; Samandouras G
World Neurosurg; 2021 Jul; 151():e217-e233. PubMed ID: 33866029
[TBL] [Abstract][Full Text] [Related]
8. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
Sanai N; Polley MY; Berger MS
J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
[TBL] [Abstract][Full Text] [Related]
9. 5-Aminolevulinic Acid Hydrochloride (5-ALA)-Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(9):1-92. PubMed ID: 32194883
[TBL] [Abstract][Full Text] [Related]
10. Preoperative prognostic classification system for hemispheric low-grade gliomas in adults.
Chang EF; Smith JS; Chang SM; Lamborn KR; Prados MD; Butowski N; Barbaro NM; Parsa AT; Berger MS; McDermott MM
J Neurosurg; 2008 Nov; 109(5):817-24. PubMed ID: 18976070
[TBL] [Abstract][Full Text] [Related]
11. Effect of Treatment Modalities on Progression-Free Survival and Overall Survival in Molecularly Subtyped World Health Organization Grade II Diffuse Gliomas: A Systematic Review.
Ghaffari-Rafi A; Samandouras G
World Neurosurg; 2020 Jan; 133():366-380.e2. PubMed ID: 31473344
[TBL] [Abstract][Full Text] [Related]
12. Biopsy versus resection for the management of low-grade gliomas.
Jiang B; Chaichana K; Veeravagu A; Chang SD; Black KL; Patil CG
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD009319. PubMed ID: 28447767
[TBL] [Abstract][Full Text] [Related]
13. Surgical assessment of the insula. Part 2: validation of the Berger-Sanai zone classification system for predicting extent of glioma resection.
Hervey-Jumper SL; Li J; Osorio JA; Lau D; Molinaro AM; Benet A; Berger MS
J Neurosurg; 2016 Feb; 124(2):482-8. PubMed ID: 26339856
[TBL] [Abstract][Full Text] [Related]
14. Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases.
Tang C; Zhang ZY; Chen LC; Sun Z; Zhang Y; Qin Z; Yao Y; Zhou LF
J Neurooncol; 2016 Feb; 126(3):499-507. PubMed ID: 26586262
[TBL] [Abstract][Full Text] [Related]
15. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
[TBL] [Abstract][Full Text] [Related]
17. Distinct IDH1/IDH2 mutation profiles in purely insular versus paralimbic WHO Grade II gliomas.
Gozé C; Mansour L; Rigau V; Duffau H
J Neurosurg; 2013 Apr; 118(4):866-72. PubMed ID: 23330999
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative imaging technology to maximise extent of resection for glioma.
Jenkinson MD; Barone DG; Bryant A; Vale L; Bulbeck H; Lawrie TA; Hart MG; Watts C
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012788. PubMed ID: 29355914
[TBL] [Abstract][Full Text] [Related]
19. Image guided surgery for the resection of brain tumours.
Barone DG; Lawrie TA; Hart MG
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009685. PubMed ID: 24474579
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of IDH mutations in gliomas: a meta-analysis of 55 observational studies.
Xia L; Wu B; Fu Z; Feng F; Qiao E; Li Q; Sun C; Ge M
Oncotarget; 2015 Jul; 6(19):17354-65. PubMed ID: 26220714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
